SEC Filing Summary: Heatwurx, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Heatwurx, Inc., a Delaware corporation, on May 27, 2015. The report addresses a corporate governance event regarding the departure of a director. Note: The request metadata references "Processa Pharmaceuticals, Inc.," but the filing text explicitly identifies the registrant as Heatwurx, Inc.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a disclosure of personnel changes and contains no financial data.
Material Changes
On May 27, 2015, Glenn Russell resigned from his position as a director of the Company. The filing states there were no disagreements between Mr. Russell and the Company on any matter relating to operations, policies, or practices.
Guidance, Outlook, and Risks
The filing does not contain guidance, outlook, management commentary on future performance, or specific risk factors beyond the standard disclosure of the director's resignation.
Key Facts for Investor Verification
- Glenn Russell resigned as a director on May 27, 2015.
- The resignation was not due to any known disagreement with the Company.
- The report was signed by Heather Kearns, Interim Chief Executive Officer, on June 2, 2015.
- No financial performance data is included in this specific filing.